What is Global Live-type Poultry Vaccine Market?
The Global Live-type Poultry Vaccine Market is a specialized segment within the broader animal health industry, focusing on vaccines that use live, attenuated pathogens to immunize poultry against various diseases. These vaccines are crucial for maintaining the health and productivity of poultry, which is a significant source of protein worldwide. The market encompasses a range of vaccines designed to combat specific diseases that affect poultry, such as chickens, turkeys, ducks, and other birds. The use of live-type vaccines is preferred in many cases because they tend to provide longer-lasting immunity and can stimulate a more comprehensive immune response compared to inactivated vaccines. The market is driven by the increasing demand for poultry products, the need for efficient disease management in poultry farming, and advancements in vaccine technology. Additionally, the rise in poultry diseases due to intensive farming practices has necessitated the development and deployment of effective vaccines. The market is characterized by continuous research and development efforts aimed at improving vaccine efficacy, safety, and delivery methods. As the global population continues to grow, the demand for poultry and, consequently, the need for effective vaccination programs is expected to rise, making this market a critical component of the global food supply chain.
Newcastle Disease Vaccine, Infectious Bronchitis Vaccine, Fowl Pox Vaccine, Marek’s Disease Vaccine, Fowl Typhoid Vaccine, Live Coccidiosis Vaccine, Other in the Global Live-type Poultry Vaccine Market:
The Global Live-type Poultry Vaccine Market includes several key vaccines, each targeting specific diseases that pose significant threats to poultry health. The Newcastle Disease Vaccine is one of the most widely used, as Newcastle disease is a highly contagious viral infection that affects many species of birds, causing respiratory distress, nervous system disorders, and reduced egg production. This vaccine is crucial for preventing outbreaks that can lead to significant economic losses in the poultry industry. The Infectious Bronchitis Vaccine targets a coronavirus that affects the respiratory tract of chickens, leading to decreased productivity and increased mortality. This vaccine is essential for maintaining the health of flocks and ensuring optimal production levels. The Fowl Pox Vaccine is used to prevent fowl pox, a viral disease that causes lesions on the skin and can lead to decreased growth rates and egg production. Marek’s Disease Vaccine is another critical component of the market, targeting a herpesvirus that causes tumors and paralysis in chickens. This vaccine has been instrumental in reducing the incidence of Marek’s disease, which can have devastating effects on poultry populations. The Fowl Typhoid Vaccine is used to protect against Salmonella Gallinarum, a bacterial infection that can cause high mortality rates in poultry. Live Coccidiosis Vaccine is designed to combat coccidiosis, a parasitic disease that affects the intestinal tract of poultry, leading to poor growth and feed conversion. This vaccine is particularly important in intensive farming operations where the risk of coccidiosis is high. Other vaccines in the market address various diseases, each playing a vital role in comprehensive poultry health management. The development and deployment of these vaccines are supported by ongoing research and innovation, ensuring they remain effective against evolving strains of pathogens. The market is also characterized by collaborations between vaccine manufacturers, research institutions, and poultry producers to enhance vaccine efficacy and accessibility. As the poultry industry continues to expand, the demand for these vaccines is expected to grow, highlighting their importance in ensuring food security and economic stability.
Chicken, Other Poultry in the Global Live-type Poultry Vaccine Market:
The usage of Global Live-type Poultry Vaccine Market is particularly significant in the context of chickens, which are the most widely farmed poultry species worldwide. Chickens are susceptible to a range of diseases that can severely impact their health and productivity. Live-type vaccines are employed to protect chickens from these diseases, ensuring their well-being and optimizing production outcomes. For instance, the Newcastle Disease Vaccine is routinely administered to chickens to prevent outbreaks that can lead to high mortality rates and economic losses. Similarly, the Infectious Bronchitis Vaccine is crucial for maintaining respiratory health in chickens, preventing productivity losses due to illness. The Marek’s Disease Vaccine is another essential tool in chicken farming, as it protects against a disease that can cause tumors and paralysis, significantly affecting flock health. In addition to chickens, live-type vaccines are also used in other poultry species, such as turkeys, ducks, and geese. These birds are also vulnerable to various diseases that can impact their health and productivity. For example, the Fowl Pox Vaccine is used in turkeys to prevent fowl pox, a disease that can cause lesions and reduce growth rates. The Live Coccidiosis Vaccine is particularly important in intensive farming operations involving multiple poultry species, as coccidiosis is a common and costly disease in such settings. The use of live-type vaccines in these areas helps to ensure the health and productivity of diverse poultry populations, supporting the overall efficiency and sustainability of poultry farming operations. The adoption of these vaccines is driven by the need to manage disease risks effectively, reduce mortality rates, and enhance the quality and quantity of poultry products. As the demand for poultry continues to rise globally, the role of live-type vaccines in supporting poultry health and productivity becomes increasingly important. These vaccines not only contribute to the economic viability of poultry farming but also play a critical role in ensuring food security by supporting the production of safe and healthy poultry products.
Global Live-type Poultry Vaccine Market Outlook:
In 2024, the Global Live-type Poultry Vaccine Market was valued at approximately $966 million, with projections indicating it could reach around $1,292 million by 2031, reflecting a compound annual growth rate (CAGR) of 4.3% over the forecast period. This growth is indicative of the increasing importance of live-type vaccines in maintaining poultry health and productivity. According to Vetnosis, the global animal health industry saw a 12% increase in value, reaching $38.3 billion in 2021. This growth underscores the expanding focus on animal health and the critical role vaccines play in this sector. In China, the pet medical industry has also seen significant growth, with the market size reaching approximately 67.5 billion yuan, accounting for about 22.5% of the entire pet industry. This data highlights the growing awareness and investment in animal health, including the poultry sector, as stakeholders recognize the importance of effective disease management in ensuring the sustainability and profitability of animal farming operations. The increasing market size and growth rates reflect the ongoing demand for innovative and effective vaccines that can address the evolving challenges faced by the poultry industry. As the market continues to expand, it is expected to drive further advancements in vaccine technology and delivery methods, enhancing the overall efficacy and accessibility of live-type poultry vaccines.
| Report Metric | Details |
| Report Name | Live-type Poultry Vaccine Market |
| Accounted market size in year | US$ 966 million |
| Forecasted market size in 2031 | US$ 1292 million |
| CAGR | 4.3% |
| Base Year | year |
| Forecasted years | 2025 - 2031 |
| Segment by Type |
|
| Segment by Application |
|
| Consumption by Region |
|
| By Company | MERCK, Boehringer Ingelheim, ELANCO, QYH BIOTECH, CEVA, ZOETIS, Vaxxinova, PULIKE, PHIBRO ANIMAL HEALTH CORPORATION, JINYU BIOTECHNOLOGY, HARBIN PHARMACEUTICAL GROUP, MEVAC |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
